PL1608655T3 - Pochodne piroloimidazolowe, ich wytwarzanie, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako środków o działaniu nootropowym - Google Patents

Pochodne piroloimidazolowe, ich wytwarzanie, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako środków o działaniu nootropowym

Info

Publication number
PL1608655T3
PL1608655T3 PL04741432T PL04741432T PL1608655T3 PL 1608655 T3 PL1608655 T3 PL 1608655T3 PL 04741432 T PL04741432 T PL 04741432T PL 04741432 T PL04741432 T PL 04741432T PL 1608655 T3 PL1608655 T3 PL 1608655T3
Authority
PL
Poland
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
nootropic agents
action
Prior art date
Application number
PL04741432T
Other languages
English (en)
Inventor
Carlo Farina
Stefania Gagliardi
Carlo Parini
Marisa Martinelli
Carla Ghelardini
Original Assignee
Neurotune Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurotune Ag filed Critical Neurotune Ag
Publication of PL1608655T3 publication Critical patent/PL1608655T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL04741432T 2003-03-24 2004-03-22 Pochodne piroloimidazolowe, ich wytwarzanie, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako środków o działaniu nootropowym PL1608655T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000573A ITMI20030573A1 (it) 2003-03-24 2003-03-24 Composti ad azione nootropica, loro preparazione,
PCT/EP2004/050339 WO2004085438A2 (en) 2003-03-24 2004-03-22 Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents
EP04741432A EP1608655B8 (en) 2003-03-24 2004-03-22 Pyrroloimidazole derivatives, their preparation, pharmaceutical compositions containing them, and their use as nootropic agents

Publications (1)

Publication Number Publication Date
PL1608655T3 true PL1608655T3 (pl) 2009-03-31

Family

ID=33042696

Family Applications (2)

Application Number Title Priority Date Filing Date
PL378939A PL378939A1 (pl) 2003-03-24 2004-03-22 Związki z działaniem nootropowym, ich wytwarzanie, zawierające je kompozycje farmaceutyczne i ich zastosowanie
PL04741432T PL1608655T3 (pl) 2003-03-24 2004-03-22 Pochodne piroloimidazolowe, ich wytwarzanie, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako środków o działaniu nootropowym

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL378939A PL378939A1 (pl) 2003-03-24 2004-03-22 Związki z działaniem nootropowym, ich wytwarzanie, zawierające je kompozycje farmaceutyczne i ich zastosowanie

Country Status (23)

Country Link
US (3) US7544705B2 (pl)
EP (1) EP1608655B8 (pl)
JP (1) JP4920408B2 (pl)
CN (1) CN100522963C (pl)
AT (1) ATE401327T1 (pl)
AU (1) AU2004224087B2 (pl)
BR (1) BRPI0408601A (pl)
CA (1) CA2520008C (pl)
CY (1) CY1108401T1 (pl)
DE (1) DE602004015089D1 (pl)
DK (1) DK1608655T3 (pl)
EA (1) EA009558B1 (pl)
ES (1) ES2309534T3 (pl)
HR (1) HRP20050833A2 (pl)
IT (1) ITMI20030573A1 (pl)
NO (1) NO20054898L (pl)
NZ (1) NZ543154A (pl)
PL (2) PL378939A1 (pl)
PT (1) PT1608655E (pl)
RS (1) RS20050725A (pl)
SI (1) SI1608655T1 (pl)
WO (1) WO2004085438A2 (pl)
ZA (1) ZA200508578B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
EP1925304A1 (en) * 2006-11-15 2008-05-28 Nikem Research S.R.L. Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents
ITMI20070770A1 (it) * 2007-04-16 2008-10-17 Brane Discovery S R L Impiego di dimiracetam nel trattamento del dolore cronico
AU2012201853B2 (en) * 2007-04-16 2013-06-27 Neurotune Ag Use of dimiracetam in the treatment of chronic pain
EP2346500B1 (en) 2008-10-16 2017-05-17 The Johns Hopkins University Methods and compositions for improving cognitive function
US9125898B2 (en) 2008-11-14 2015-09-08 Neurotune Ag Acetam derivatives for pain relief
EP2533645B1 (en) * 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
PL2598504T3 (pl) * 2010-07-26 2014-10-31 Neurotune Ag Sposób otrzymywania dimiracetamu
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
US10806717B2 (en) 2013-03-15 2020-10-20 The Johns Hopkins University Methods and compositions for improving cognitive function
CA2904767C (en) 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function
EA034167B8 (ru) 2015-05-22 2021-04-27 Эйджинбайо, Инк. Фармацевтические композиции леветирацетама пролонгированного высвобождения
JOP20190251A1 (ar) 2017-05-31 2019-10-21 Metys Pharmaceuticals AG تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
EA202191486A1 (ru) 2018-12-04 2021-09-14 Метис Фармасьютиклз Аг СИНЕРГЕТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ R-2-(ЗАМЕЩЕННЫЙ СУЛЬФОНИЛ)ГЕКСАГИДРОПИРРОЛО[1,2-а]ПИРАЗИН-6(2H)ОНЫ И S-2-(ЗАМЕЩЕННЫЙ СУЛЬФОНИЛ)ГЕКСАГИДРОПИРРОЛО[1,2-а]ПИРАЗИН-6(2H)ОНЫ В НЕРАЦЕМИЧЕСКОМ СООТНОШЕНИИ
JP2022510363A (ja) 2018-12-04 2022-01-26 メティス ファーマシューティカルズ アクチェンゲゼルシャフト (r)-2-(2-オキソピロリジン-1-イル)ブタンアミドと(s)-2-(2-オキソピロリジン-1-イル)ブタンアミドを非ラセミ比で含む相乗的組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582838A (en) 1984-08-24 1986-04-15 Warner-Lambert Company Derivatives of dihydro-1H-pyrrolo[1,2-c]imidazol-3,5-dione as cognition activators
IT1233860B (it) * 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
US5200406A (en) * 1988-02-08 1993-04-06 I.S.F. Societa Per Azioni Pharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepines
JP3400466B2 (ja) * 1991-10-28 2003-04-28 日本水産株式会社 高純度エイコサペンタエン酸またはそのエステルの製造方法
GB9123641D0 (en) 1991-11-07 1992-01-02 Isf Spa Process
ITMI20030573A1 (it) * 2003-03-24 2004-09-25 Nikem Research Srl Composti ad azione nootropica, loro preparazione,
EP1925304A1 (en) * 2006-11-15 2008-05-28 Nikem Research S.R.L. Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents

Also Published As

Publication number Publication date
CN1756757A (zh) 2006-04-05
WO2004085438A2 (en) 2004-10-07
PL378939A1 (pl) 2006-06-12
WO2004085438A3 (en) 2004-11-25
AU2004224087B2 (en) 2010-04-01
ES2309534T3 (es) 2008-12-16
NO20054898L (no) 2005-10-24
JP2006523198A (ja) 2006-10-12
EA200501501A1 (ru) 2006-04-28
DE602004015089D1 (de) 2008-08-28
US7732473B2 (en) 2010-06-08
JP4920408B2 (ja) 2012-04-18
NZ543154A (en) 2008-03-28
ZA200508578B (en) 2007-04-25
EP1608655A2 (en) 2005-12-28
US20070027137A1 (en) 2007-02-01
DK1608655T3 (da) 2008-11-03
ITMI20030573A1 (it) 2004-09-25
US20090163565A1 (en) 2009-06-25
HK1083837A1 (en) 2006-07-14
EP1608655B1 (en) 2008-07-16
CA2520008A1 (en) 2004-10-07
RS20050725A (sr) 2007-11-15
US7544705B2 (en) 2009-06-09
US20100173945A1 (en) 2010-07-08
PT1608655E (pt) 2008-10-07
CN100522963C (zh) 2009-08-05
HRP20050833A2 (en) 2006-02-28
CY1108401T1 (el) 2014-02-12
AU2004224087A1 (en) 2004-10-07
BRPI0408601A (pt) 2006-03-07
CA2520008C (en) 2011-08-23
ATE401327T1 (de) 2008-08-15
EA009558B1 (ru) 2008-02-28
SI1608655T1 (sl) 2008-12-31
EP1608655B8 (en) 2008-10-15

Similar Documents

Publication Publication Date Title
SI1608655T1 (sl) Derivati piroloimidazola, njihova priprava, farmacevtske sestave, ki jih vsebujejo, in njihova rabakot nutropiäśnih sredstev
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
TNSN04113A1 (en) 3-â-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
MXPA05007462A (es) Derivados de pirrolopiridazina.
AU2004263179A8 (en) Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
ZA200706029B (en) Tricyclic &-opioid domulators
WO2005004802A3 (en) N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
MY140488A (en) Substituted oxazolidinones and their use in the field of blood coagulation
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
TW200716546A (en) Oxindole compounds and their uses as therapeutic agents
IL181700A0 (en) Quinazoline derivatives and pharmaceutical compositions containing the same
CA2473070A1 (en) Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
IL176110A0 (en) Azabicyclic heterocycles as cannabinoid receptor modulators
TW200724543A (en) Heterocyclic compounds and their uses as therapeutic agents
WO2004110376A3 (en) Ccr-2 antagonists for treatment of neuropathic pain
UA86024C2 (ru) Трициклические дельта-опиоидные модуляторы
YU75603A (sh) Dihidropirimidinska jedinjenja koja su supstituisana na cijano grupi i njihova upotreba u lečenju oboljenja
IL175819A0 (en) Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease
TNSN06403A1 (en) 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
MX2008002234A (es) Inhibidores de sulfonamida n-biciclico puenteados de gamma secretasa.
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
TW200621767A (en) Tricyclic δ-opioid modulators
WO2002076930A3 (en) Substituted diarylureas as stimulators for fas-mediated apoptosis
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
GB0522908D0 (en) Therapeutic agents